We are a pre-clinical stage startup innovating drug delivery systems (DDS) based on a simple-mixing, self-assembling porous hydrogel without chemical cross-linking. Our technology can deliver a variety of active pharmaceutical ingredients (APIs) with controlled release and long-lasting effects. Our drug-loaded gel offers multiple injection routes, custom formulations with slow-release kinetics, and the ability to mix multiple APIs. As a GMP clinical-grade DDS, we aim to transform therapeutics across various clinical settings.

We are developing solutions for complex indications like solid tumours while actively seeking partnerships to expand the application of our platform. Join us in shaping the future of targeted, controlled-release therapeutics.

Injectable DDS
The drug loaded porous hydrogel matrix can be injected into various body sites, including:
•	Intradermal (into the skin)
•	Tissues
•	Organs
•	Intra-articular joints (within joints)
•	Tumours
Topical DDS
The drug loaded porous hydrogel can also applied topically for skin conditions like psoriasis. Our platform addresses critical challenges in treating psoriasis and atopic dermatitis by combining multiple therapeutic agents in a novel formulation that enables precise, controlled drug delivery through topical application

PNAS Therapeutics

Org chart

Teams

Offices